Peter L D Wildfong
Overview
Explore the profile of Peter L D Wildfong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bookwala M, Shi J, Buckner I, Bates S, Wildfong P
J Pharm Sci
. 2024 Oct;
114(1):416-423.
PMID: 39426565
Thermodynamic properties, including solubility and miscibility, which are highly correlated with amorphous solid dispersion physical stability were identified for the complex solid forms of bromopropamide using simultaneous X-ray diffraction (XRD)-differential...
2.
3.
DeBoyace K, Bookwala M, Zhou D, Buckner I, Wildfong P
Mol Pharm
. 2024 Jan;
21(2):770-780.
PMID: 38181202
The 3 molecular descriptor (R-GETAWAY third-order autocorrelation index weighted by the atomic mass) has previously been shown to encode molecular attributes that appear to be physically and chemically relevant to...
4.
Wildfong P, Haware R, Engers D
Pharm Res
. 2023 Dec;
40(12):2759-2760.
PMID: 38133785
No abstract available.
5.
6.
Manchanda A, Bookwala M, Wildfong P, Bogner R
Pharm Res
. 2023 Sep;
40(12):2769-2778.
PMID: 37667146
Purpose: The pharmaceutical literature contains examples wherein desupersaturation from high concentrations does not proceed to equilibrium concentration of the thermodynamically most stable form but remains above equilibrium. The purpose of...
7.
Bookwala M, Wildfong P
Pharm Res
. 2023 Jul;
40(12):2887-2902.
PMID: 37523015
Purpose: To compare the prediction accuracy of two models used to characterize the complete disordering potential of materials after extensive cryogenic milling. Methods: Elastic shear moduli (μ) were simulated in...
8.
Bookwala M, Wildfong P
Pharm Res
. 2023 Jun;
40(12):2963-2981.
PMID: 37389801
Amorphous solid dispersions (ASDs) are a formulation and development strategy that can be used to increase the apparent aqueous solubility of poorly water-soluble drugs. Their implementation, however, can be hindered...
9.
Gumireddy A, Bookwala M, Zhou D, Wildfong P, Buckner I
J Pharm Sci
. 2022 Nov;
112(1):318-327.
PMID: 36351478
Evaluation of different amorphous solid dispersion carrier matrices is enabled by active pharmaceutical ingredient (API) structure-based predictions. This study compares the utility of Hansen Solubility Parameters with the R3m molecular...
10.
Bookwala M, Buckner I, Wildfong P
Mol Pharm
. 2022 Sep;
19(11):3959-3972.
PMID: 36049226
Specific noncovalent drug-polymer interactions were analytically identified using Raman and Fourier transform infrared spectroscopy for amorphous solid dispersions (ASD) formed between either chlorpropamide or tolbutamide and polyvinylpyrrolidone vinyl acetate random...